{"id":"https://openalex.org/W4225856497","doi":"https://doi.org/10.1016/j.euroneuro.2022.03.006","title":"Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: ,\u03b1-DEPEA and DPIA","display_name":"Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: ,\u03b1-DEPEA and DPIA","publication_year":2022,"publication_date":"2022-04-01","ids":{"openalex":"https://openalex.org/W4225856497","doi":"https://doi.org/10.1016/j.euroneuro.2022.03.006","pmid":"https://pubmed.ncbi.nlm.nih.gov/35378384"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2022.03.006","doi":"https://doi.org/10.1016/j.euroneuro.2022.03.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2022.03.006","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X22001560/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0924977X22001560/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055068028","display_name":"Karolina E. Kolaczynska","orcid":"https://orcid.org/0000-0003-1714-0758","observed_orcids":["https://orcid.org/0000-0003-1714-0758"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Karolina E. Kolaczynska","raw_affiliation_strings":["Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003469311","display_name":"Paula Ducret","orcid":"https://orcid.org/0000-0002-4690-4051","observed_orcids":["https://orcid.org/0000-0002-4690-4051"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Paula Ducret","raw_affiliation_strings":["Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-4690-4051","affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel Trachsel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Trachsel","raw_affiliation_strings":["ReseaChem GmbH, Burgdorf, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ReseaChem GmbH, Burgdorf, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039060911","display_name":"Marius Christian Hoener","orcid":"https://orcid.org/0000-0001-6510-6250","observed_orcids":["https://orcid.org/0000-0001-6510-6250"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marius C. Hoener","raw_affiliation_strings":["Neuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-6510-6250","affiliations":[{"raw_affiliation_string":"Neuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071962736","display_name":"Matthias E. Liechti","orcid":"https://orcid.org/0000-0002-1765-9659","observed_orcids":["https://orcid.org/0000-0002-1765-9659"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Matthias E. Liechti","raw_affiliation_strings":["Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: matthias.liechti@usb.ch","Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: matthias.liechti@usb.ch","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034015135","display_name":"Dino Luethi","orcid":"https://orcid.org/0000-0003-0874-4875","observed_orcids":["https://orcid.org/0000-0003-0874-4875"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT","CH"],"is_corresponding":false,"raw_author_name":"Dino Luethi","raw_affiliation_strings":["Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria","Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria","Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-0874-4875","affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5071962736"],"corresponding_institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":1.2713,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.7774033,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"59","issue":null,"first_page":"9","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.4758000075817108,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.4758000075817108,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.44510000944137573,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.053599998354911804,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/3-4-methylenedioxyamphetamine","display_name":"3,4-methylenedioxyamphetamine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/entactogens","display_name":"entactogens","score":0.7170000076293945},{"id":"https://openalex.org/keywords/monoamine-transporters","display_name":"monoamine transporters","score":0.7129999995231628},{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.7099999785423279},{"id":"https://openalex.org/keywords/dopamine-transporter","display_name":"dopamine transporter","score":0.9629999995231628},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.7670000195503235},{"id":"https://openalex.org/keywords/5-ht2c-receptor","display_name":"5-HT2C receptor","score":0.9490000009536743},{"id":"https://openalex.org/keywords/5-ht2b-receptor","display_name":"5-HT2B receptor","score":0.9279999732971191},{"id":"https://openalex.org/keywords/adrenergic-receptors","display_name":"adrenergic receptors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/taar1","display_name":"TAAR1","score":0.9670000076293945},{"id":"https://openalex.org/keywords/street-drugs","display_name":"street drugs","score":0.48100000619888306},{"id":"https://openalex.org/keywords/sports-supplements","display_name":"sports supplements","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7886689901351929},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.7749509811401367},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.7740037441253662},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7035884857177734},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5973957180976868},{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.5415520668029785},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.535233199596405},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5229488015174866},{"id":"https://openalex.org/C2776755682","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine transporter","level":4,"score":0.5213462114334106},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.4278339147567749},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.41136232018470764},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3789956271648407},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2682989835739136},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16460639238357544},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10064271092414856},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015104","descriptor_name":"3,4-Methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015104","descriptor_name":"3,4-Methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015104","descriptor_name":"3,4-Methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.euroneuro.2022.03.006","doi":"https://doi.org/10.1016/j.euroneuro.2022.03.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2022.03.006","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X22001560/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:35378384","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35378384","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.euroneuro.2022.03.006","doi":"https://doi.org/10.1016/j.euroneuro.2022.03.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2022.03.006","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X22001560/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7900000214576721}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1744533436","display_name":null,"funder_award_id":"16.921318","funder_id":"https://openalex.org/F4320321099","funder_display_name":"Bundesamt f\u00fcr Gesundheit"},{"id":"https://openalex.org/G4310822664","display_name":"Serotonin transporter oligomerization as potential target of antidepressants and drugs of abuse","funder_award_id":"191032","funder_id":"https://openalex.org/F4320320924","funder_display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung"},{"id":"https://openalex.org/G5788712033","display_name":null,"funder_award_id":"16.921318","funder_id":"https://openalex.org/F4320320924","funder_display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320320924","display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","ror":"https://ror.org/00yjd3n13"},{"id":"https://openalex.org/F4320321099","display_name":"Bundesamt f\u00fcr Gesundheit","ror":"https://ror.org/01qtc5416"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4225856497.pdf","grobid_xml":"https://content.openalex.org/works/W4225856497.grobid-xml"},"referenced_works_count":83,"referenced_works":["https://openalex.org/W973825046","https://openalex.org/W1168686445","https://openalex.org/W1490334811","https://openalex.org/W1572907996","https://openalex.org/W1581024190","https://openalex.org/W1600370546","https://openalex.org/W1836264777","https://openalex.org/W1842708150","https://openalex.org/W1873978593","https://openalex.org/W1924654066","https://openalex.org/W1937517990","https://openalex.org/W1958575417","https://openalex.org/W1973660081","https://openalex.org/W1974723685","https://openalex.org/W1992963529","https://openalex.org/W1995835731","https://openalex.org/W2002956985","https://openalex.org/W2011428797","https://openalex.org/W2012520776","https://openalex.org/W2018365125","https://openalex.org/W2018849904","https://openalex.org/W2024947346","https://openalex.org/W2033963679","https://openalex.org/W2041645298","https://openalex.org/W2048867733","https://openalex.org/W2050938735","https://openalex.org/W2053248244","https://openalex.org/W2056758002","https://openalex.org/W2059248417","https://openalex.org/W2063087523","https://openalex.org/W2063915017","https://openalex.org/W2064576666","https://openalex.org/W2067100416","https://openalex.org/W2089306255","https://openalex.org/W2090563027","https://openalex.org/W2090826913","https://openalex.org/W2092679508","https://openalex.org/W2095199220","https://openalex.org/W2100561434","https://openalex.org/W2100718942","https://openalex.org/W2102057063","https://openalex.org/W2105566727","https://openalex.org/W2107779923","https://openalex.org/W2108827491","https://openalex.org/W2125885488","https://openalex.org/W2126087777","https://openalex.org/W2126609598","https://openalex.org/W2134599163","https://openalex.org/W2140674423","https://openalex.org/W2141190015","https://openalex.org/W2142137999","https://openalex.org/W2146415111","https://openalex.org/W2151540952","https://openalex.org/W2162382085","https://openalex.org/W2166675380","https://openalex.org/W2295029219","https://openalex.org/W2322566395","https://openalex.org/W2411442112","https://openalex.org/W2415485176","https://openalex.org/W2582692487","https://openalex.org/W2734417270","https://openalex.org/W2738047805","https://openalex.org/W2746927775","https://openalex.org/W2798640434","https://openalex.org/W2805248302","https://openalex.org/W2903547094","https://openalex.org/W2914255920","https://openalex.org/W2938925240","https://openalex.org/W2943605891","https://openalex.org/W2944263526","https://openalex.org/W3014121938","https://openalex.org/W3026842400","https://openalex.org/W3093375227","https://openalex.org/W3136598136","https://openalex.org/W3160990818","https://openalex.org/W3170563218","https://openalex.org/W3213514609","https://openalex.org/W4211150788","https://openalex.org/W4302397257","https://openalex.org/W6640399486","https://openalex.org/W6663459217","https://openalex.org/W6681823813","https://openalex.org/W6716328739"],"related_works":["https://openalex.org/W3013387849","https://openalex.org/W2127854642","https://openalex.org/W2983486486","https://openalex.org/W2070332167","https://openalex.org/W2411084178","https://openalex.org/W1966369144","https://openalex.org/W4301512469","https://openalex.org/W2074429989","https://openalex.org/W2004687905","https://openalex.org/W4396849929"],"abstract_inverted_index":{"3,4-methylenedioxyamphetamine":[0],"(MDA)":[1],"is":[2],"a":[3],"psychoactive":[4],"compound":[5],"chemically":[6],"related":[7,42],"to":[8,155,222,230],"the":[9,16,35,56,75,97,102,109,125,148,168,186,193,207,233,239],"entactogen":[10],"MDMA.":[11,210],"MDA":[12,39,121,204],"shares":[13],"some":[14,200],"of":[15,19,38,142,150,199,209,238],"entactogenic":[17],"effects":[18,25],"MDMA":[20],"but":[21],"also":[22],"exerts":[23],"stimulant":[24],"and":[26,41,64,84,87,101,112,124,130,157,164,170,185,202,214,225,235],"psychedelic":[27],"properties":[28,37],"at":[29,143],"higher":[30],"doses.":[31],"Here,":[32],"we":[33,80],"examined":[34,55],"pharmacological":[36,58,197],"analogs":[40,205],"amphetamine-based":[43,126],"compounds":[44,153,180],"detected":[45],"in":[46,51,192],"street":[47],"drug":[48],"samples":[49],"or":[50,175],"sport":[52],"supplements.":[53],"We":[54],"key":[57],"mechanisms":[59],"including":[60],"monoamine":[61,82,146],"uptake":[62],"inhibition":[63],"release":[65],"using":[66],"human":[67,77],"embryonic":[68],"kidney":[69],"293":[70],"cells":[71],"stably":[72],"transfected":[73],"with":[74,108,147,182],"respective":[76],"transporters.":[78],"Additionally,":[79],"assessed":[81],"transporter":[83],"receptor":[85,172,189],"binding":[86],"activation":[88],"properties.":[89],"MDA,":[90],"its":[91],"fluorinated":[92,201],"analogs,":[93],"as":[94,96,173],"well":[95],"\u03b1-ethyl":[98],"containing":[99],"BDB":[100],"dimeric":[103],"amphetamine":[104],"DPIA":[105],"inhibited":[106,114,128,132],"NET":[107,129],"greatest":[110],"potency":[111],"preferentially":[113,131],"5-HT":[115,135],"vs.":[116,134],"dopamine":[117,133],"uptake.":[118,136],"The":[119,137,196],"\u03b2\u2011methoxy":[120],"analog":[122],"3C-BOH":[123,213],"N,\u03b1-DEPEA":[127,215],"test":[138],"drugs":[139],"mediated":[140],"efflux":[141],"least":[144],"one":[145],"exception":[149],"DPIA.":[151],"Most":[152],"bound":[154],"5-HT2A":[156,169],"5-HT2C":[158],"receptors":[159,184],"(Ki":[160],"\u2264":[161],"10":[162],"\u00b5M)":[163],"several":[165,179],"substances":[166],"activated":[167],"5-HT2B":[171],"partial":[174],"full":[176],"agonists.":[177],"Furthermore,":[178],"interacted":[181],"adrenergic":[183],"trace":[187],"amine-associated":[188],"1":[190],"(TAAR1)":[191],"micromolar":[194],"range.":[195],"profiles":[198],"nonfluorinated":[203],"resemble":[206],"profile":[208],"In":[211],"contrast,":[212],"displayed":[216],"more":[217],"pronounced":[218],"dopaminergic":[219],"activity":[220],"similar":[221],"amphetamine.":[223],"Pharmacokinetics":[224],"pharmacodynamics":[226],"studies":[227],"are":[228],"necessary":[229],"better":[231],"establish":[232],"risks":[234],"therapeutic":[236],"potential":[237],"tested":[240],"drugs.":[241]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-05T00:00:00"}